Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
KDI
Kennady Diamonds
C$2.95
-1.7%
C$2.95
C$2.45
C$3.86
C$150.19MN/A39,418 shs1,000 shs
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
C$0.00
C$1.66
C$4.85
C$553.23MN/A669,999 shs1.96 million shs
McEwen Inc. stock logo
MUX
McEwen
$10.94
-1.9%
$9.27
$6.38
$11.46
$591.17M0.98719,962 shs585,489 shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$64.32
-1.5%
$70.34
$57.00
$139.74
$287.14B0.647.38 million shs8.03 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
KDI
Kennady Diamonds
0.00%0.00%0.00%0.00%0.00%
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
0.00%0.00%0.00%0.00%0.00%
McEwen Inc. stock logo
MUX
McEwen
0.00%+0.09%+15.71%+35.48%+9.73%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.00%-6.69%-13.11%+10.92%-52.50%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
KDI
Kennady Diamonds
N/AN/AN/AN/AN/AN/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/AN/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
2.2769 of 5 stars
3.61.00.00.03.30.80.6
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
4.2332 of 5 stars
3.14.02.50.03.40.03.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
KDI
Kennady Diamonds
0.00
N/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
0.00
N/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
3.20
Buy$14.3331.02% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.27
Hold$112.0074.13% Upside

Current Analyst Ratings Breakdown

Latest KDI, KDX, NVO, and MUX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
McEwen Inc. stock logo
MUX
McEwen
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
7/1/2025
McEwen Inc. stock logo
MUX
McEwen
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$12.00 ➝ $15.00
6/24/2025
McEwen Inc. stock logo
MUX
McEwen
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/9/2025
McEwen Inc. stock logo
MUX
McEwen
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $15.50
4/29/2025
McEwen Inc. stock logo
MUX
McEwen
National Bank Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/28/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/25/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Dbs Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeSell
(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
KDI
Kennady Diamonds
N/AN/AN/AN/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
$174.48M3.39N/AN/A$9.35 per share1.17
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$303.14B0.95$3.90 per share16.49$4.66 per share13.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
KDI
Kennady Diamonds
N/AN/A0.00N/AN/AN/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/A0.00N/AN/AN/AN/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
-$43.69M-$0.57N/AN/AN/A-17.51%-6.03%-4.37%8/6/2025 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$14.64B$3.3819.0313.801.2434.52%80.94%24.23%8/6/2025 (Estimated)

Latest KDI, KDX, NVO, and MUX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
McEwen Inc. stock logo
MUX
McEwen
$0.09N/AN/AN/A$49.05 millionN/A
8/6/2025Q2 2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.89N/AN/AN/A$77.51 billionN/A
5/7/2025Q1 2025
McEwen Inc. stock logo
MUX
McEwen
-$0.14-$0.12+$0.02-$0.12$39.06 million$35.70 million
5/7/2025Q1 2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.92$0.92N/A$0.92N/A$11.87 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
KDI
Kennady Diamonds
N/AN/AN/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
N/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.632.53%N/A48.22%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
KDI
Kennady Diamonds
N/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/A
McEwen Inc. stock logo
MUX
McEwen
0.26
2.35
1.89
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.70
0.74
0.56

Institutional Ownership

CompanyInstitutional Ownership
KDI
Kennady Diamonds
N/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A
McEwen Inc. stock logo
MUX
McEwen
17.03%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%

Insider Ownership

CompanyInsider Ownership
KDI
Kennady Diamonds
N/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A
McEwen Inc. stock logo
MUX
McEwen
16.10%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
KDI
Kennady Diamonds
N/A50.91 millionN/ANot Optionable
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A180.21 millionN/ANot Optionable
McEwen Inc. stock logo
MUX
McEwen
43053.99 million45.30 millionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
77,3494.47 billion4.46 billionOptionable

Recent News About These Companies

Novo Nordisk Has So Much Room To Go
Bailard Inc. Boosts Stake in Novo Nordisk A/S (NYSE:NVO)
Pecaut & CO. Takes Position in Novo Nordisk A/S (NYSE:NVO)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Kennady Diamonds CVE:KDI

C$2.95 -0.05 (-1.67%)
As of 04/17/2018

Kennady Diamonds Inc. engages in the discovery, evaluation, exploration, and development of diamond properties in Canada. It owns a 100% interest in the Kennady North diamond project that comprises 22 federal leases and 58 mineral claims covering an area of 67,164.17 hectares located in the north-east of Yellowknife, Northwest Territories. The company was incorporated in 2012 and is based in Toronto, Canada.

Klondex Mines stock logo

Klondex Mines TSE:KDX

Klondex Mines Ltd., together with its subsidiaries, acquires, explores, develops, and produces mineral properties in the United States and Canada. It primarily explores for gold and silver deposits. The company holds 100% interests in the Fire Creek mine covering approximately 19,000 acres located in Lander County; the Midas mine and ore milling facility covering approximately 30,000 acres situated in Elko County; and the Hollister mine approximately 18,000 acres located in Elko County. It also has 100% interests in the True North gold mine and mill covering approximately 39,868 hectares situated in Manitoba, Canada; and the Aurora mine and ore milling facility covering approximately 5,004 contiguous acres located in Nevada, as well as in the Ogama-Rockland property in Manitoba, Canada. The company was formerly known as Attila Resources Limited and changed its name to Klondex Mines Ltd. in October 1974. Klondex Mines Ltd. was founded in 1971 and is headquartered in Reno, Nevada.

McEwen stock logo

McEwen NYSE:MUX

$10.94 -0.21 (-1.88%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$10.95 +0.01 (+0.09%)
As of 07/18/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McEwen Mining Inc. engages in the exploration, development, production, and sale of gold and silver. It also explores for copper deposits. The company owns 100% interests in the El Gallo and Fenix projects located in Mexico; and the Black Fox Mine and Stock Mill, Grey Fox, and Froome and Tamarack properties in Canada. It also owns interests in the Fuller, Davidson-Tisdale, Buffalo Ankerite, and Paymaster exploration properties located in Canada; and a 49% interest in the San José mine located in Argentina. In addition, the company owns 100% interests in the Gold Bar and Tonkin properties located in Eureka County, Nevada; and interests in the Los Azules copper project located in the cordilleran region in the province of San Juan, Argentina. The company was formerly known as US Gold Corporation and changed its name to McEwen Mining Inc. in January 2012. McEwen Mining Inc. was founded in 1979 and is headquartered in Toronto, Canada.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$64.32 -0.97 (-1.49%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$64.39 +0.07 (+0.11%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.